Cargando…
HMGB-1 as a Potential Target for the Treatment of Diabetic Retinopathy
BACKGROUND: Diabetic retinopathy (DR) is one of the most important complications of diabetes mellitus (DM) and is the leading cause of blindness in diabetic patients. Recent studies showed that as important inflammatory mediators, high mobility group box 1 (HMGB-1) is associated with diabetic periph...
Autores principales: | Zhao, Hailan, Zhang, Jingzhuang, Yu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604733/ https://www.ncbi.nlm.nih.gov/pubmed/26454330 http://dx.doi.org/10.12659/MSM.894453 |
Ejemplares similares
-
Identification and validation of hub genes for diabetic retinopathy
por: Peng, Li, et al.
Publicado: (2021) -
Association of potential salivary biomarkers with diabetic retinopathy and its severity in type-2 diabetes mellitus: a proteomic analysis by mass spectrometry
por: Chee, Chin Soon, et al.
Publicado: (2016) -
Effects of Glucan and Vitamin D Supplementation on Obesity and Lipid Metabolism in Diabetic Retinopathy
por: Závorková, Martina, et al.
Publicado: (2018) -
Muscone improves hypoxia/reoxygenation (H/R)-induced neuronal injury by blocking HMGB1/TLR4/NF-κB pathway via modulating microRNA-142
por: Ren, Weihua, et al.
Publicado: (2022) -
m(6)A reader IGF2BP1 accelerates apoptosis of high glucose-induced vascular endothelial cells in a m(6)A-HMGB1 dependent manner
por: Liang, Anru, et al.
Publicado: (2023)